J. Safra Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8K Hold
64
– – ﹤0.01% 307
2026
Q1
$18.7K Sell
64
-26
-29% -$8.54K ﹤0.01% 311
2025
Q4
$31.6K Buy
+90
New +$30.4K ﹤0.01% 302
2023
Q3
– Sell
-55
Closed -$24.4K – 111
2023
Q2
$24.4K Hold
55
– – ﹤0.01% 92
2023
Q1
$25.3K Buy
+55
New +$26.2K ﹤0.01% 93

Other funds holding ELV

J. Safra Asset Management's ELV Position: Q2 2026 in Review

J. Safra Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 64 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

J. Safra Asset Management first reported a position in ELV in Q1 2023 and has held it in 5 quarters since. The position peaked at $31.6K in Q4 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • J. Safra Asset Management held 64 shares of Elevance Health worth $24.8K as of Q2 2026.
  • J. Safra Asset Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #307 holding.
  • J. Safra Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 5 quarters since.
  • J. Safra Asset Management's Elevance Health position peaked at $31.6K in Q4 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.